Therefore, accumulating data provide underlying connections among the PTEN, PI3K/Akt pathway, multidrug resistance transporters, stem-like character, and therapeutic resistance, suggesting that activation of this pathway also enhances the ability of CML cancer stem-like cells to expel drugs. The gene discussed is PTEN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.